Skip to content
Search

Latest Stories

Power outage disrupts GPhC registration assessment for 3 hours

Power outage disrupts GPhC registration assessment for 3 hours
GPhC registration assessment for summer 2024 required candidates to have satisfactorily completed 39 weeks of training on or before 3 May 2024 

On Thursday (27) the Chief Operating Officer at the General Pharmaceutical Council (GPhC), Jonathan Bennetts, reported a major power cut at London Highbury test centre that caused major delays in the examination process.

London Highbury test centre is amongst 87 centres where the GPhC's registration assessment for summer 2024 took place which required candidates to have completed 39 weeks of training on or before May 3 and with satisfactory 39 weeks of training progress report.


Bennetts reported that approximately 2,700 candidates sat for the registration assessment  when at one of the centres "unexpected power outage caused a three-hour delay."

"Around seventy candidates at the London Highbury test centre were unable to start Part 2 of the assessment at the scheduled time of 2:15 PM," Bennetts stated.

The unexpected power outage caused a three-hour delay, during which candidates were kept informed and provided with refreshments.

Additional GPhC representatives were dispatched to the centre to support the affected candidates.

The power was restored after three hours, allowing the candidates to commence Part 2 of the examination.

Essential checks were conducted to ensure everything was in order before resuming the assessment.

Bennetts acknowledged the inconvenience caused by the delay, emphasising the GPhC's awareness of the stress it might have induced among the candidates.

"We fully understand the impact that the power cut may have had on these candidates and the stress this will have caused," he said.

The GPhC is taking proactive steps to address the issue by reaching out to the affected candidates via email.

In their communication, they are extending their apologies and providing an explanation of the candidates' options.

Additionally, the GPhC is encouraging candidates to contact them if they wish to discuss these options further.

Despite the significant disruption at the London Highbury test centre, Bennetts reported that the rest of the 86 centres conducting the registration assessment experienced no significant issues.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less